NYR 12.0% 4.4¢ nyrada inc.

Ann: Significant Neuroprotection in NYR Preclinical Brain Injury, page-176

  1. 10,189 Posts.
    lightbulb Created with Sketch. 1986
    Biggest quarter ahead from the company and peers after the pre clinical success and 8 years of development to this point are trading at 70-100 million market caps. 10 million market cap with 10 million in funding is a joke. The below tells you where this is going. Should be trading at a 60-70 cent share price leading into phase 2 but it’s coming


    https://hotcopper.com.au/data/attachments/6256/6256656-b76532be0f00d12a866607691362e14d.jpg

    Last edited by Roch2077: 19/06/24
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.